Financials

  • Market Capitalization 2.33 B
  • Employee 357
  • Founded 2009
  • CEO N/A
  • Website www.nurixtx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDJ8M78
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-5.54
Fiyat/satışlar oranı
17.45

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
1823
SLS
SELLAS Life Sciences Group, Inc. - Common Stock
12.02 USD+3.18%+4.34%+10.17%+507.07%2.43 B USD
1831
IRON
Disc Medicine, Inc. - Common Stock
61.28 USD-1.26%-3.33%-12.53%-12.72%2.35 B USD
1842
CLDX
Celldex Therapeutics, Inc. - Common Stock
29.54 USD-1.17%-9.41%-21.02%+8.44%2.32 B USD
1843
ADMA
ADMA Biologics Inc - Common Stock
10.32 USD-0.39%+2.69%+10.61%-29.12%2.31 B USD

Haberler